Due to Covid-19, global demand for drugs and vaccines is growing rapidly. In response, manufacturers of biologics, sterile injectables, vaccines and cell and gene therapies are increasingly turning to the Growth Direct platform offered by Rapid Micro Systems.

The membrane surrounding cells acts as a selective barrier. Scientists have therefore struggled to engineer efficient methods of delivering nanomaterials, such as DNA, proteins and drugs, into cells. Now, Korean researchers have developed a rapid and efficient delivery method that uses the power of a tiny fluid vortex to deform the cell membranes.

Orgenesis has entered into an agreement with the John Hopkins University under which the institue will make use of Orgenesis’ point-of-care (Pocare) platform to devlop and supply a wide range of cell and gene therapies and technologies.

Following the trend towards biopharmaceutical medicine Sartorius launched for its ambr 250 modular benchtop automated mini bioreactor system new vessels, which are designed for gentle stirring and optimum growth of cell lines. The system allows cost-effective, scalable process development of cell and gene therapies.